| Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene A Cascón, I Comino-Méndez, M Currás-Freixes, AA de Cubas, ... Journal of the National Cancer Institute 107 (5), djv053, 2015 | 250 | 2015 |
| Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients M Currás-Freixes, L Inglada-Pérez, V Mancikova, C Montero-Conde, ... Journal of medical genetics 52 (10), 647-656, 2015 | 136 | 2015 |
| Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas L Remacha, D Pirman, CE Mahoney, J Coloma, B Calsina, ... The American Journal of Human Genetics 104 (4), 651-664, 2019 | 94 | 2019 |
| PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics M Currás-Freixes, E Piñeiro-Yañez, C Montero-Conde, M Apellániz-Ruiz, ... The Journal of molecular diagnostics 19 (4), 575-588, 2017 | 83 | 2017 |
| Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma B Calsina, LJ Castro-Vega, R Torres-Pérez, L Inglada-Pérez, ... Theranostics 9 (17), 4946, 2019 | 67 | 2019 |
| Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in … R Garcia-Carbonero, R Garcia-Figueiras, A Carmona-Bayonas, I Sevilla, ... Cancer and Metastasis Reviews 34, 823-842, 2015 | 63 | 2015 |
| Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors P Jiménez-Fonseca, A Carmona-Bayonas, E Martín-Pérez, G Crespo, ... Cancer and Metastasis Reviews 34, 381-400, 2015 | 57 | 2015 |
| Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma B Calsina, E Piñeiro-Yáñez, ÁM Martínez-Montes, E Caleiras, ... Nature communications 14 (1), 1122, 2023 | 52 | 2023 |
| Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up P Valderrábano, J Aller, L García-Valdecasas, J García-Uría, L Martín, ... Endocrinología y Nutrición (English Edition) 61 (4), 176-183, 2014 | 51 | 2014 |
| Pasireotide in the personalized treatment of acromegaly M Puig-Domingo, I Bernabéu, A Picó, B Biagetti, J Gil, C Alvarez-Escolá, ... Frontiers in endocrinology 12, 648411, 2021 | 50 | 2021 |
| Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience G Crespo, P Jiménez-Fonseca, A Custodio, C López, ... Future Oncology 13 (7), 615-624, 2016 | 48 | 2016 |
| Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer J Capdevila, K Newbold, L Licitra, A Popovtzer, F Moreso, J Zamorano, ... Cancer Treatment Reviews 69, 164-176, 2018 | 42 | 2018 |
| A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly PJ Trainer, JDC Newell-Price, J Ayuk, SJB Aylwin, A Rees, W Drake, ... European Journal of Endocrinology 179 (2), 97-108, 2018 | 41 | 2018 |
| No clinically significant valvular regurgitation in long‐term cabergoline treatment for prolactinoma I Halperin, J Aller, C Varela, M Mora, A Abad, A Doltra, AE Santos, ... Clinical endocrinology 77 (2), 275-280, 2012 | 41 | 2012 |
| Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC) J Capdevila, JM Trigo, J Aller, JL Manzano, SG Adrián, CZ Llopis, Ò Reig, ... European Journal of Endocrinology 177 (4), 309-317, 2017 | 39 | 2017 |
| Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment M Campderá, N Palacios, J Aller, R Magallón, P Martín, G Saucedo, ... Pituitary 19, 158-166, 2016 | 36 | 2016 |
| Translational research in neuroendocrine tumors: pitfalls and opportunities J Capdevila, O Casanovas, R Salazar, D Castellano, A Segura, P Fuster, ... Oncogene 36 (14), 1899-1907, 2017 | 30 | 2017 |
| Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus I Bernabeu, J Aller, C Álvarez-Escolá, C Fajardo-Montañana, ... Endocrinología, Diabetes y Nutrición (English ed.) 65 (5), 297-305, 2018 | 28 | 2018 |
| Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY I Bernabeu, A Pico, E Venegas, J Aller, C Alvarez-Escolá, ... Pituitary 19, 127-137, 2016 | 28 | 2016 |
| Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma C Rodriguez-Antona, I Muñoz, L Inglada-Perez, AA de Cubas, ... Endocrine-related cancer, 2013 | 23 | 2013 |
Ignacio BernabeuClinical EndocrinologistDirección de correo verificada de sergas.es
